Clinical Trial Update: A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade

View source ↗

Summary

A clinical trial using single-cell analysis to identify biomarkers of pulmonary toxicity from immune checkpoint blockade is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Pneumonitis
• Pneumonitis

Drugs mentioned

• Immune checkpoint inhibitors (various)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Pneumonitis, Interstitial, Immunotherapy | Status: RECRUITING